PT81150B - Processo para a preparacao duma vacina contra o virus da hepatite a em primatas - Google Patents

Processo para a preparacao duma vacina contra o virus da hepatite a em primatas

Info

Publication number: PT81150B
Authority: PT; Portugal
Prior art keywords: primates; virus; preparation; vaccine against; against hepatitis
Prior art date: 1984-09-19

Application number

PT81150A

Other languages

English (en)

Other versions

PT81150A (en

Inventor

Robert H Purcell

Richard J Daemer

Stephen M Feinstone

Ian D Gust

Original Assignee

Us Health

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1984-09-19

Filing date

1985-09-18

Publication date

1987-10-20

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24615385&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT81150(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1985-09-18 Application filed by Us Health filed Critical Us Health

1985-10-01 Publication of PT81150A publication Critical patent/PT81150A/pt

1987-10-20 Publication of PT81150B publication Critical patent/PT81150B/pt

Links

241000709721 Hepatovirus A Species 0.000 title 1
241000288906 Primates Species 0.000 title 1
229960005486 vaccine Drugs 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/04—Inactivation or attenuation; Producing viral sub-units
- C12N7/08—Inactivation or attenuation by serial passage of virus
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
- C12N2770/32434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
- C12N2770/32451—Methods of production or purification of viral material
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
- C12N2770/32461—Methods of inactivation or attenuation
- C12N2770/32464—Methods of inactivation or attenuation by serial passage
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Virology (AREA)
Microbiology (AREA)
Medicinal Chemistry (AREA)
Immunology (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Genetics & Genomics (AREA)
Bioinformatics & Cheminformatics (AREA)
Mycology (AREA)
Epidemiology (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Communicable Diseases (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Peptides Or Proteins (AREA)
Medicinal Preparation (AREA)

PT81150A 1984-09-19 1985-09-18 Processo para a preparacao duma vacina contra o virus da hepatite a em primatas PT81150B (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US06/652,067 US4620978A (en)	1982-04-07	1984-09-19	Hepatitis A virus purified and triply cloned

Publications (2)

Publication Number	Publication Date
PT81150A PT81150A (en)	1985-10-01
PT81150B true PT81150B (pt)	1987-10-20

Family

ID=24615385

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT81150A PT81150B (pt)	1984-09-19	1985-09-18	Processo para a preparacao duma vacina contra o virus da hepatite a em primatas

Country Status (16)

Country	Link
US (1)	US4620978A (pt)
EP (1)	EP0196316A4 (pt)
JP (1)	JPS62500659A (pt)
KR (1)	KR860700263A (pt)
AU (1)	AU583306B2 (pt)
CA (1)	CA1260392A (pt)
DK (1)	DK227786D0 (pt)
ES (1)	ES8701837A1 (pt)
FI (1)	FI86376C (pt)
GR (1)	GR852293B (pt)
IL (1)	IL76417A (pt)
NO (1)	NO169601C (pt)
NZ (1)	NZ213513A (pt)
PT (1)	PT81150B (pt)
WO (1)	WO1986001826A1 (pt)
ZA (1)	ZA857134B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
USRE37381E1 (en) *	1982-04-07	2001-09-18	The United States Of America As Represented By The Department Of Health And Human Services	Vaccine against hepatitis A virus
US4894228A (en) *	1982-04-07	1990-01-16	The United States Of America As Represented By The Department Of Health And Human Services	Vaccine against hepatitis A virus
JPH085804B2 (ja) *	1988-04-28	1996-01-24	財団法人化学及血清療法研究所	Ａ型及びｂ型肝炎混合アジュバントワクチン
US5268292A (en) *	1988-06-27	1993-12-07	Robertson Betty H	Reproducible generation of high yields of hepatitis A virus by cell culture
NZ256278A (en) *	1992-09-18	1996-11-26	Smithkline Beecham Biolog	Live attenuated hepatitis a virus adapted to grow in mrc-5 cells
EP1175912A1 (en) *	1993-03-23	2002-01-30	SmithKline Beecham Biologics SA	Vaccine compositions containing 3-O deacylated monophosphoryl lipid A
HRP950097A2 (en)	1994-03-08	1997-06-30	Merck & Co Inc	Hepatitis a virus culture process
US5766906A (en) *	1994-07-11	1998-06-16	The University Of North Carolina At Chapel Hill	Hepatitis A virus deletion mutants and vaccine formulations containing the same
US10265265B2 (en) *	2007-03-15	2019-04-23	Drug Delivery Solutions Limited	Topical composition

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4164566A (en) *	1978-08-17	1979-08-14	Merck & Co., Inc.	Hepatitis a virus cell culture in vitro
US4532215A (en) *	1982-04-07	1985-07-30	The United States Of America As Represented By The Department Of Health And Human Services	Isolation of hepatitis A virus strain HM-175

1984
- 1984-09-19 US US06/652,067 patent/US4620978A/en not_active Expired - Lifetime
1985
- 1985-09-17 NZ NZ213513A patent/NZ213513A/xx unknown
- 1985-09-17 ZA ZA857134A patent/ZA857134B/xx unknown
- 1985-09-18 AU AU48620/85A patent/AU583306B2/en not_active Expired
- 1985-09-18 WO PCT/US1985/001769 patent/WO1986001826A1/en not_active Application Discontinuation
- 1985-09-18 JP JP60504247A patent/JPS62500659A/ja active Pending
- 1985-09-18 PT PT81150A patent/PT81150B/pt unknown
- 1985-09-18 KR KR860700275A patent/KR860700263A/ko not_active Application Discontinuation
- 1985-09-18 CA CA000491066A patent/CA1260392A/en not_active Expired
- 1985-09-18 EP EP19850904746 patent/EP0196316A4/en not_active Ceased
- 1985-09-19 IL IL76417A patent/IL76417A/xx not_active IP Right Cessation
- 1985-09-19 ES ES547115A patent/ES8701837A1/es not_active Expired
- 1985-09-20 GR GR852293A patent/GR852293B/el unknown
1986
- 1986-04-24 NO NO86861619A patent/NO169601C/no not_active IP Right Cessation
- 1986-05-12 FI FI861966A patent/FI86376C/fi not_active IP Right Cessation
- 1986-05-16 DK DK227786A patent/DK227786D0/da active IP Right Revival

Also Published As

Publication number	Publication date
IL76417A0 (en)	1986-01-31
DK227786A (da)	1986-05-16
NO169601C (no)	1992-07-15
GR852293B (pt)	1986-01-21
ZA857134B (en)	1987-05-27
JPS62500659A (ja)	1987-03-19
FI86376C (fi)	1992-08-25
CA1260392A (en)	1989-09-26
EP0196316A4 (en)	1987-01-28
ES8701837A1 (es)	1986-12-01
NO169601B1 (no)	1992-04-06
US4620978A (en)	1986-11-04
WO1986001826A1 (en)	1986-03-27
IL76417A (en)	1990-12-23
KR860700263A (ko)	1986-08-01
AU583306B2 (en)	1989-04-27
AU4862085A (en)	1986-04-08
FI861966A0 (fi)	1986-05-12
PT81150A (en)	1985-10-01
DK227786D0 (da)	1986-05-16
FI86376B (fi)	1992-05-15
NZ213513A (en)	1989-03-29
EP0196316A1 (en)	1986-10-08
FI861966A (fi)	1986-05-12
NO861619A (no)	1986-04-24
ES547115A0 (es)	1986-12-01

Publication	Publication Date	Title
BR8603901A (pt)	1987-03-24	Processo para a preparacao de 2-oxo-1,3-dioxolanas e seu uso
PT89365A (pt)	1989-12-29	Processo para a preparacao de composicoes de goma de mascar com estabilidade fisica melhorada
PT90293A (pt)	1989-11-10	Processo para a preparacao de macrolidos
PT84561B (pt)	1989-11-10	Processo aperfeicoado para a preparacao de derivados macrolidos
PT91895A (pt)	1990-04-30	Processo para a preparacao de 9h-purinas substituidas
PT97621A (pt)	1992-03-31	Processo para a preparacao de vacinas contra o papilomavirus humano 18 (hpv 18)
PT83344A (pt)	1986-10-01	Processo para a preparacao de ypsilon-carbolinas antipsicoticas
PT90854A (pt)	1989-12-29	Processo para a preparacao de 1-aril-2-naftoilaminas
BR8906327A (pt)	1990-08-21	Processo para a preparacao de organoclorossilanos
PT81150B (pt)	1987-10-20	Processo para a preparacao duma vacina contra o virus da hepatite a em primatas
PT92638A (pt)	1990-06-29	Processo para a preparacao de poliazamacrociclos mono-n-alquilados
PT92365A (pt)	1990-05-31	Processo para a preparacao de (s)-alfa-etil-2-oxo-1-pirrolidinoacetamida
PT91160A (pt)	1990-02-08	Processo para a preparacao de um novo heteropolissacarido bm07
PT91783A (pt)	1990-03-30	Processo para a preparacao de {(diarilmetoxi) alquil}-1-pirrolidinas e piperidinas
PT80264B (pt)	1987-10-20	Processo para a preparacao de derivados de hidroxi-4-2h-1-benzotiopiran-2-onas
PT89204A (pt)	1989-12-29	Processo para a preparacao de um agente edulcorante
PT81526B (pt)	1988-03-03	Processo para a preparacao de novas homopropargilaminas
BR8504879A (pt)	1986-07-22	Derivados de amino-alcool e processo para a preparacao dos mesmos
BR8902030A (pt)	1989-12-05	Processo para a preparacao de n-fosfonometilglicina
PT81061B (pt)	1987-11-11	Processo para a preparacao de um polipeptideo vacinico
BR8905629A (pt)	1990-06-05	Processo para a preparacao de n-fosfonometil-glicina
PT80044B (pt)	1987-10-20	Processo para a preparacao de concentrados emulsionaveis contendo azois
PT83154B (pt)	1989-03-30	Processo para a preparacao de quinolizino-sulfonamidas
BR8806348A (pt)	1989-08-22	Hidrocarbilsililoxido cerico e processo para a preparacao do mesmo
BR8906056A (pt)	1990-06-26	Processo para a preparacao de alcanosulfonamidas